BioSpace News Archive

Genetown

CereVasc’s eShunt® System Study Data Presented at the ABC WIN Seminar

CereVasc, Inc. announced that data from its clinical studies in the United States and Argentina, examining the use of its eShunt System to treat communicating hydrocephalus, was presented at the ABC WIN Seminar in Val d’Isere.

January 23, 2024
·
2 min read
Business

HDT Bio Receives $749,000 EZBAA Contract and Partners with BARDA Under Project NextGen’s Enabler’s Program

HDT Bio Corp. today announced that it has partnered with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, under Project NextGen’s Enabler’s program.

January 23, 2024
·
3 min read
Business

Neuromod Devices Announces Finance Leadership Reorganisation

Neuromod Devices Ltd. has announced reorganisation of the company’s finance responsibilities within its Senior Management Team.

January 23, 2024
·
3 min read
Genetown

Cognito Therapeutics Announces First Patient Enrolled in HOPE Biomarker Study

Cognito Therapeutics announced today the first patient enrolled in a biomarker substudy within the HOPE pivotal trial .

January 23, 2024
·
3 min read
Business

Incyte to Report Fourth Quarter and Year-End 2023 Financial Results

Incyte (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2023 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, February 13, 2024.

January 23, 2024
·
1 min read
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at University of Utah, an Internationally Recognized Center in Obstetrics and Gynecology

Femasys Inc. today announced that it has activated enrollment for its pivotal FemBloc trial at another academic site, University of Utah Hospital in Salt Lake City, Utah.

January 23, 2024
·
6 min read
Lone Star Bio

Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device – the Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) System

Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office (USPTO) has awarded U.S. Patent No. 11,872,397 relating to the Company’s non-invasive, frequency-based deep brain stimulation device.

January 23, 2024
·
4 min read
Biotech Beach

Crown Bioscience’s Global Oncology Research Facilities Achieve Prestigious ISO and CAP Accreditations

Crown Bioscience , a global contract research organization (CRO) and JSR Life Sciences company, proudly announces that its global laboratory facilities have successfully passed a series of annual on-site ISO audits, achieving a flawless record with zero discrepancies.

January 23, 2024
·
2 min read
Biotech Bay

Performance Validation Joins ValGenesis Partner Program as Service Partner for the U.S. Market

ValGenesis Inc. and Performance Validation, Inc. have partnered to deliver unique compliance-focused digital validation solutions for life sciences companies in the US.

January 23, 2024
·
3 min read
Business

Vivtex Enters Research Collaboration with Astellas Pharma

Vivtex Corporation announces that it has entered a research collaboration with Astellas Pharma Inc. (“Astellas”), a global pharmaceutical company.

January 23, 2024
·
2 min read